• share
• favorite_border

Sukru Emre, MD, has been profiled as one of New York's top doctors, for his life-changing triple liver transplant.

• share
• favorite_border

A state-of-the-art, live demonstration of complex coronary and vascular interventions, and a presentation of the latest in interventional medicine by internationally recognized experts will take place at a symposium Wednesday, June 15th -- Friday, June 17th.

• share
• favorite_border

After the sale of Infinity Broadcasting Corporation, a company he had founded, Michael A. Wiener had the opportunity to dedicate himself to his love of photography, his beautiful home in Connecticut and the Cardiovascular Institute at Mount Sinai Medical Center.

• share
• favorite_border

David Adams, MD has earned a sought after position in New York magazine's Best Doctors in New York issue due on newsstands Monday, June 6. Dr. Adams will be profiled in the 2005 issue that focused on physicians who have impacted the life of their patient through life-saving treatment.

• share
• favorite_border

Financier Leon D. Black has committed $10 million to Mount Sinai School of Medicine to establish the Black Family Stem Cell Institute. The Institute will integrate research in embryonic stem cells, developmental biology, and adult stem cell biology.

• share
• favorite_border

SV40 does not have a role in the majority of malignant mesotheliomas -- a cancer associated with exposure to asbestos. The study used a scrupulous protocol that eliminated contamination.

• share
• favorite_border

Charles Pagnam has joined The Mount Sinai Medical Center as Senior Vice President for Development. Long-time Yale fund-raiser brings broad experience to leading academic medical center.

• share
• favorite_border

David Muller, MD has been appointed Dean of Medical Education of Mount Sinai School of Medicine. Dr. Muller has a well earned reputation as a most innovative and gifted medical educator. At Mount Sinai, he has consistently been recognized by students as a role model.

• share
• favorite_border

The Mount Sinai Medical Center has received a certificate of recognition from the New York State Commissioner of Health for advancing patient safety through its innovative Medication Safety Reporting System.

• share
• favorite_border

Researchers at Mount Sinai School of Medicine have found alpha-defensin-1, a protein found in immune cells, can control HIV infection by at least two mechanisms. Earlier studies have primarily looked at the role of defensins in bacterial diseases.

• share
• favorite_border

Mount Sinai School of Medicine's renowned Mini-Med School will begin it's free, 4-week spring session on March 29th. This well-known lecture series offers a unique opportunity for anyone interested in medical topics to learn from world-renowned physicians and scientists.

• share
• favorite_border

Mount Sinai School of Medicine researchers demonstrated that a gel applied in the vagina provides protection from both the human immunodeficiency virus (HIV) and the herpes simplex virus.

• share
• favorite_border

Surgeons have found that less cutting is more beneficial to patients undergoing arthroscopic repair for lateral epicondylitis, also called "˜tennis elbow.'

• share
• favorite_border

Researchers identified a protein that might trigger kidney disease in diabetic patients, a condition that affects one in three people with type 1 and one in ten people with type 2 diabetes.

• share
• favorite_border

A single gene variant may increase a man's risk of prostate cancer by 50%, according to a new study led by researchers at Mount Sinai School of Medicine.

• share
• favorite_border

The Mount Sinai Medical Center has drafted baseball legend Yogi Berra to lead an effort to call attention to the danger of abdominal aortic aneurysms, a little-recognized silent killer that takes as many as 15-thousands of lives each year, but can be detected early by ultrasound screening and treated with minimally-invasive surgery.

• share
• favorite_border

JAMA has published the findings of a study which indicates that ximelagatran, a novel anti-clotting medication currently under development, prevents strokes and systemic embolic events in patients with nonvalvular atrial fibrillation as effectively as current treatment with warfarin.

• share
• favorite_border

A research team led by investigators from the Massachusetts General Hospital (MGH) has identified and cloned the gene responsible for early-onset dystonia, a crippling, inherited neurological disorder that begins in childhood. The discovery, announced in the September issue of Nature Genetics, is the culmination of more than 15 years of work and contains important clues that could lead to better understanding of the disease and possible preventive treatments.